Mesa Laboratories (MLAB) Cash & Current Investments (2010 - 2025)

Mesa Laboratories has disclosed Cash & Current Investments across 16 years of filings, most recently posting $30.5 million for Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $30.5 million, up 6.32% year-over-year; the trailing twelve-month figure through Dec 2025 was $30.5 million (up 6.32% YoY), and the FY2025 annual result was $29.1 million, down 3.45% from the prior year.
• Cash & Current Investments came in at $30.5 million for Q4 2025 at Mesa Laboratories, up from $21.9 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $278.3 million in Q3 2021 to a low of $21.9 million in Q3 2025.
• The 5-year median for Cash & Current Investments is $32.1 million (2023), against an average of $69.1 million.
• Across the five-year window, Cash & Current Investments soared 224.24% in 2021 and tumbled 87.36% in 2022, its largest moves.
• Mesa Laboratories' Cash & Current Investments stood at $51.7 million in 2021, then tumbled by 46.23% to $27.8 million in 2022, then climbed by 9.22% to $30.4 million in 2023, then dropped by 5.62% to $28.7 million in 2024, then rose by 6.32% to $30.5 million in 2025.
• The last three Cash & Current Investments figures came in at $30.5 million (Q4 2025), $21.9 million (Q3 2025), and $23.0 million (Q2 2025), per Business Quant data.